{"id":37839,"date":"2025-11-05T12:38:53","date_gmt":"2025-11-05T05:38:53","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=37839"},"modified":"2025-11-05T12:38:53","modified_gmt":"2025-11-05T05:38:53","slug":"molnlycke-establishes-first-wound-care-manufacturing-site-in-china","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=37839","title":{"rendered":"M\u00f6lnlycke\u00ae establishes first wound care manufacturing site in China"},"content":{"rendered":"\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

CHANGSHU, China<\/span> and GOTHENBURG, Sweden<\/span><\/span>, Nov. 5, 2025<\/span><\/span> \/PRNewswire\/ — M\u00f6lnlycke\u00ae Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden<\/span>, is celebrating the commencement of its new wound care manufacturing site in Changshu, China<\/span>. This strategic investment marks a milestone in M\u00f6lnlycke’s growth journey and the beginning of localised manufacturing in one of the world’s fastest-growing MedTech markets.<\/p>\n

\"M\u00f6lnlycke<\/a>
M\u00f6lnlycke establishes first wound care manufacturing site in China, marked by a commencement ceremony in Changshu.<\/span> <\/div>\n

“Our site in Changshu marks another step forward in M\u00f6lnlycke’s ambition to manufacture products closer to where they are sold. It reflects our glocal<\/i> approach, combining global standards with local relevance, and reinforces our commitment to sustainable growth, supply chain resilience and faster delivery of life-changing wound care solutions to caregivers and patients in China<\/span>,” says Zlatko Rihter, CEO of M\u00f6lnlycke.<\/p>\n

The manufacturing site, spanning 10,000 m<\/span>2<\/sup>, will be set up in accordance with M\u00f6lnlycke’s global standards and is expected to initiate production of M\u00f6lnlycke wound care products at the end of 2026\/early 2027. This strategic move will help future-proof M\u00f6lnlycke’s growth in China<\/span>, laying the foundation for future capacity expansion and local job creation.<\/p>\n

“This investment brings us closer to our customers in China<\/span> and reinforces our mission to free patients and caregivers from the burden of wounds, with locally produced, high-quality solutions,” adds Jakob Sonnenberg<\/span>, VP Greater China & India Wound Care at M\u00f6lnlycke.<\/p>\n

The Changshu site strengthens M\u00f6lnlycke’s position in Asia<\/span> and aligns with China’s<\/span> growing demand for advanced, locally manufactured healthcare solutions.<\/p>\n

For more information, please contact:<\/b><\/p>\n

Jamie Smith<\/span>
Media Relations Manager
Email: jamie.smith@molnlycke.<\/a>com<\/a>
Phone: +46 (0)722-553573<\/p>\n

About M\u00f6lnlycke\u00a0<\/b><\/p>\n

M\u00f6lnlycke Health Care is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. M\u00f6lnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world.\u00a0Founded in 1849,\u00a0M\u00f6lnlycke is owned by Investor AB and headquartered in Sweden.\u00a0www.molnlycke.com<\/a><\/p>\n

\u00a0<\/p>","protected":false},"excerpt":{"rendered":"

<\/p>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

CHANGSHU, China<\/span> and GOTHENBURG, Sweden<\/span><\/span>, Nov. 5, 2025<\/span><\/span> \/PRNewswire\/ — M\u00f6lnlycke\u00ae Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden<\/span>, is celebrating the commencement of its new wound care manufacturing site in Changshu, China<\/span>. This strategic investment marks a milestone in M\u00f6lnlycke’s growth journey and the beginning of localised manufacturing in one of the world’s fastest-growing MedTech markets.<\/p>\n

\"M\u00f6lnlycke<\/a>
M\u00f6lnlycke establishes first wound care manufacturing site in China, marked by a commencement ceremony in Changshu.<\/span> <\/div>\n

“Our site in Changshu marks another step forward in M\u00f6lnlycke’s ambition to manufacture products closer to where they are sold. It reflects our glocal<\/i> approach, combining global standards with local relevance, and reinforces our commitment to sustainable growth, supply chain resilience and faster delivery of life-changing wound care solutions to caregivers and patients in China<\/span>,” says Zlatko Rihter, CEO of M\u00f6lnlycke.<\/p>\n

The manufacturing site, spanning 10,000 m<\/span>2<\/sup>, will be set up in accordance with M\u00f6lnlycke’s global standards and is expected to initiate production of M\u00f6lnlycke wound care products at the end of 2026\/early 2027. This strategic move will help future-proof M\u00f6lnlycke’s growth in China<\/span>, laying the foundation for future capacity expansion and local job creation.<\/p>\n

“This investment brings us closer to our customers in China<\/span> and reinforces our mission to free patients and caregivers from the burden of wounds, with locally produced, high-quality solutions,” adds Jakob Sonnenberg<\/span>, VP Greater China & India Wound Care at M\u00f6lnlycke.<\/p>\n

The Changshu site strengthens M\u00f6lnlycke’s position in Asia<\/span> and aligns with China’s<\/span> growing demand for advanced, locally manufactured healthcare solutions.<\/p>\n

For more information, please contact:<\/b><\/p>\n

Jamie Smith<\/span>
Media Relations Manager
Email: jamie.smith@molnlycke.<\/a>com<\/a>
Phone: +46 (0)722-553573<\/p>\n

About M\u00f6lnlycke\u00a0<\/b><\/p>\n

M\u00f6lnlycke Health Care is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. M\u00f6lnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world.\u00a0Founded in 1849,\u00a0M\u00f6lnlycke is owned by Investor AB and headquartered in Sweden.\u00a0www.molnlycke.com<\/a><\/p>\n

\u00a0<\/p>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-37839","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/37839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37839"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/37839\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}